Literature DB >> 18928661

Psychosocial support of the pediatric cancer patient: lessons learned over the past 50 years.

Martha A Askins1, Bartlett D Moore.   

Abstract

Advances in pediatric cancer treatment over the past 50 years have dramatically improved survival rates. Once considered almost uniformly fatal, pediatric cancer's overall survival rates now approach 85%. Formerly, little psychosocial support existed for the child with cancer other than that provided by nurses and family. The prospect for long-term survival was so remote that plans for the future (eg, school, social relationships, late effects of treatment, and emotional adjustment) were abandoned. As the survival rate for children with cancer improved, so did the need for and quality of psychosocial care, largely because of hope for a cure. Today children with cancer benefit from comprehensive behavioral pediatric psychosocial support programs in psychiatry, psychology, neuropsychology, child life, education (school), creative arts, chaplaincy, social work, and career and vocational counseling. Pediatric psycho-oncology research has provided insights into clinical care and the psychosocial adaptation of children and families to cancer treatment and survivorship.

Entities:  

Mesh:

Year:  2008        PMID: 18928661     DOI: 10.1007/s11912-008-0072-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

1.  Prognostic factors in acute lymphoblastic leukemia.

Authors:  P S Gaynon
Journal:  J Pediatr Hematol Oncol       Date:  2000 Sep-Oct       Impact factor: 1.289

2.  Palliative care: a supportive adjunct to pediatric phase I clinical trials for anticancer agents?

Authors:  Connie M Ulrich; Christine Grady; David Wendler
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

3.  Risk factors in the adjustment of siblings of children with cancer.

Authors:  P Sloper; D While
Journal:  J Child Psychol Psychiatry       Date:  1996-07       Impact factor: 8.982

4.  Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults.

Authors:  H G Koenig; H J Cohen; L K George; J C Hays; D B Larson; D G Blazer
Journal:  Int J Psychiatry Med       Date:  1997       Impact factor: 1.210

Review 5.  Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach.

Authors:  Robert W Butler; Donna R Copeland
Journal:  J Int Neuropsychol Soc       Date:  2002-01       Impact factor: 2.892

6.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

Authors:  R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

7.  Using problem-solving skills training to reduce negative affectivity in mothers of children with newly diagnosed cancer: report of a multisite randomized trial.

Authors:  Olle Jane Z Sahler; Diane L Fairclough; Sean Phipps; Raymond K Mulhern; Michael J Dolgin; Robert B Noll; Ernest R Katz; James W Varni; Donna R Copeland; Robert W Butler
Journal:  J Consult Clin Psychol       Date:  2005-04

Review 8.  Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study.

Authors:  D R Copeland; C deMoor; B D Moore; J L Ater
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

9.  A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy.

Authors:  Robert W Butler; Donna R Copeland; Diane L Fairclough; Raymond K Mulhern; Ernest R Katz; Anne E Kazak; Robert B Noll; Sunita K Patel; Olle Jane Z Sahler
Journal:  J Consult Clin Psychol       Date:  2008-06

10.  Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study.

Authors:  Brad J Zebrack; Lonnie K Zeltzer; John Whitton; Ann C Mertens; Lorrie Odom; Roger Berkow; Leslie L Robison
Journal:  Pediatrics       Date:  2002-07       Impact factor: 9.703

View more
  8 in total

1.  What Adult Cancer Care Can Learn From Pediatrics.

Authors:  Sarah R Brand; Lucy Pickard; Jennifer W Mack; Leonard L Berry
Journal:  J Oncol Pract       Date:  2016-08-16       Impact factor: 3.840

2.  Pediatric Leukemia, Psychosocial Dimensions of Cures, and Implications for HIV.

Authors:  Catherine Gliwa; Mary E Grewe; Stuart Rennie; Joseph Tucker; Raul Necochea
Journal:  Pediatrics       Date:  2016-03-03       Impact factor: 7.124

Review 3.  Pediatric psycho-oncology care: standards, guidelines, and consensus reports.

Authors:  Lori Wiener; Adrienne Viola; Julia Koretski; Emily Diana Perper; Andrea Farkas Patenaude
Journal:  Psychooncology       Date:  2014-06-06       Impact factor: 3.894

Review 4.  Updates in paediatric psycho-oncology.

Authors:  Nicole Mavrides; Maryland Pao
Journal:  Int Rev Psychiatry       Date:  2014-02

5.  Psychosocial issues in pediatric oncology.

Authors:  Joel Marcus
Journal:  Ochsner J       Date:  2012

Review 6.  Damocles' syndrome revisited: Update on the fear of cancer recurrence in the complex world of today's treatments and survivorship.

Authors:  Margaret Cupit-Link; Karen L Syrjala; Shahrukh K Hashmi
Journal:  Hematol Oncol Stem Cell Ther       Date:  2018-02-19

7.  Movie making as a cognitive distraction for paediatric patients receiving radiotherapy treatment: qualitative interview study.

Authors:  Bradley J M Shrimpton; David J Willis; Cáthal D Tongs; Aldo G Rolfo
Journal:  BMJ Open       Date:  2013-01-16       Impact factor: 2.692

8.  Barriers to psychological care among primary caregivers of children undergoing hematopoietic stem cell transplantation.

Authors:  Katie A Devine; Sharon L Manne; Laura Mee; Abraham S Bartell; Stephen A Sands; Shannon Myers-Virtue; Pamela Ohman-Strickland
Journal:  Support Care Cancer       Date:  2015-11-17       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.